News
Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc., will launch a bioequivalent version of Adderall tablets in strengths ranging from 5 mg to 30 mg, with distribution set to ...
Europe's pharma sector now trails the US, it went on to say, "on every investor metric from availability of capital, ...
Wellness startups are launching products that target the natural growth of GLP-1, the hormone that medicines like Ozempic and ...
Three TSX stocks are suitable options for long-term investors seeking exposure to the healthcare sector. The post Why I’d Consider These Top Healthcare Stocks for a $10,000 Long-Term Investment ...
AstraZeneca's Alexion Pharmaceuticals was sued in Massachusetts federal court on Wednesday for allegedly misusing its patents ...
Abbott's diversified global supply chain and 25 new products in the pipeline position it well to navigate tariff impacts and ...
U.S. President Donald Trump on Tuesday signed an executive order that aims to delay Medicare negotiations for a broad ...
President Donald Trump has threatened tariffs on pharmaceutical imports, with U.S. Commerce Secretary Howard Lutnick confirming that the tariffs will be implemented “in a month or two,” ABC News ...
The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change ...
Barclays, in a report, says that Abbott (NYSE:ABT) and Baxter (NYSE:BAX) will be among least affected, while Johnson & ...
Medical technology and device makers are fighting for tariff exemptions, while PPE makers are applauding the levies.
The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results